Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories (ABT) is currently at $105.74, down $3.46 or 3.17%
--Would be lowest close since Dec. 8, 2023, when it closed at $104.51
--On pace for largest percent decrease since Oct. 11, 2023, when it fell 5.04%
--Currently down three of the past four days
--Down 6.96% month-to-date
--Down 3.93% year-to-date
--Down 25.25% from its all-time closing high of $141.46 on Dec. 27, 2021
--Down 5.83% from 52 weeks ago (April 19, 2023), when it closed at $112.29
--Down 12.58% from its 52-week closing high of $120.96 on March 8, 2024
--Up 17.25% from its 52-week closing low of $90.19 on Oct. 12, 2023
--Traded as low as $104.25; lowest intraday level since Dec. 11, 2023, when it hit $104.21
--Down 4.54% at today's intraday low; largest intraday percent decrease since March 15, 2024, when it fell as much as 5.54%
All data as of 10:38:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2024 10:55 ET (14:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks